Anxiety Disorders, Depression Disorders, Smoking
Conditions
Keywords
smoking, cessation, anxiety, anxious, depression, depressed, smoker, stress
Brief summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.
Interventions
DRUGNicotine Patch
BEHAVIORALDepression and Anxiety Smoking Cessation Treatment
Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies
BEHAVIORALEducational-Support Psychotherapy
Educational-based psychotherapy and standard smoking cessation treatment program
Sponsors
National Institute on Drug Abuse (NIDA)
University of Houston
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Ages 18-65 years old * Capable of providing informed consent * Willing to attend all study visits and comply with the protocol * Daily smoker for at least one year * Currently smoke an average of at least 6 cigarettes per day * Report a motivation to quit smoking in the next 6 weeks of at least 5 on a 10-point scale * Elevated anxiety or depression
Exclusion criteria
* Use of other tobacco products * Current or past psychotic disorders of any type, or comorbid psychiatric conditions that are relative or absolute contraindications to the use of any treatment option in the study protocol * Currently suicidal or high suicide risk * Current use of any pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt * Concurrent psychotherapy initiated within three months of baseline, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression * Current or intended participation in a concurrent substance abuse treatment * Current non-nicotine substance dependence * Insufficient command of English to participate in assessment or treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Smoking Status using the Timeline Follow-Back Assessment | Change from baseline at 2, 4, 8, 10, 16, and 24 weeks post quit day. | Participants will report the number of cigarettes they consumed everyday since their last visit. The number of cigarettes reported will be used to determine smoking status (e.g., 0 cigarettes reported is abstinent and any cigarettes reported is currently smoking). |
Countries
United States
Outcome results
None listed